Trademark Encyclopedia

Information about trademarks

Search for trademarks:

• 0
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

Table of contents:

• Document 85163833 overview
• GOODS AND/OR SERVICES CLASS
• DESIGN CODES
• PROSECUTION HISTORY
• Document 85163890 overview

---

---

The "KADCYLA TRASTUZUMAB EMTANSINE" trademark, serial number 85163833 , was filed on 28th of October 2010 with a mark drawing code of 3000 and its transaction date is 85163833. Since 15th of May 2012, the document can be found in the M50 law office in the publication and issue section. The employee responsible is HWANG, JOHN C B and the date it was published for opposition on 09/20/2011. The status of this trademark was checked last on 11/15/2011.

The corresponded responsible for this trademark is GENENTECH, INC., located at 1 DNA WAY, SOUTH SAN FRANCISCO, CA 94080-4918, .

The state or country where the trademark was organized is CA by Genentech, Inc.. The legal entity type behing it is a Corporation, located at 1 Dna Way, South San Francisco, CA zip 94080.Other trademarks by this applicant: NUTRIGEN, GENLIFA, SIMTROLA.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	6 - Active
Status Date	11/02/2010
Primary Code	005
International Class - 041 - Education; providing of training; entertainment; sporting and cultural activities.
U.S. Class	107 - Education and Entertainment
Class Status	6 - Active
Status Date	11/02/2010
Primary Code	041
International Class - 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
U.S. Class	101 - Advertising and Business
Class Status	6 - Active
Status Date	11/02/2010
Primary Code	044
Goods codes
CC0000	Color is not claimed as a feature of the mark.
D10000	"TRASTUZUMAB EMTANSINE"
DM0000	The mark consists of a "Y" with a semi-circle above it next to the word "KADCYLA TRASTUZUMAB EMTANSINE".
GS0051	Pharmaceutical preparations containing trastuzumab emtansine for treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, inflammatory diseases and disorders, gastro-intestinal diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, infectious diseases and disorders, metabolic diseases and disorders
GS0411	Providing educational training in the medical field
GS0441	Medical services

DESIGN SETUP

Circles, semi; Semi-circles . Circles, exactly three circles; Three circles . Circles that are totally or partially shaded. . Triangles, exactly two triangles; Two triangles . Triangles that are completely or partially shaded . Angles (geometric); Chevrons . Geometric figures forming letters, numerals or punctuation .

PROSECUTION HISTORY
Date	Description	Type	Code
05/27/2011	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
11/15/2011	NOA MAILED - SOU REQUIRED FROM APPLICANT	O - Outgoing Correspondence	NOAM - NOTICE OF ALLOWANCE-MAILED
09/20/2011	PUBLISHED FOR OPPOSITION	A - Allowance for Publication	PUBO - PUBLISHED FOR OPPOSITION
08/31/2011	NOTICE OF PUBLICATION	O - Outgoing Correspondence	NPUB - NOTICE OF PUBLICATION
08/16/2011	LAW OFFICE PUBLICATION REVIEW COMPLETED	O - Outgoing Correspondence	PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
08/12/2011	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2011	EXAMINERS AMENDMENT MAILED	O - Outgoing Correspondence	CNEA - EXAMINERS AMENDMENT MAILED
07/28/2011	EXAMINER'S AMENDMENT ENTERED	I - Incoming Correspondence	XAEC - EXAMINER'S AMENDMENT ENTERED
07/28/2011	EXAMINERS AMENDMENT -WRITTEN	R - Renewal	CNEA - EXAMINERS AMENDMENT -WRITTEN
07/21/2011	PREVIOUS ALLOWANCE COUNT WITHDRAWN	Z - Deletion	ZZZX - PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/18/2011	WITHDRAWN FROM PUB - OG REVIEW QUERY	Z - Deletion	PBCR
07/05/2011	LAW OFFICE PUBLICATION REVIEW COMPLETED	O - Outgoing Correspondence	PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
07/05/2011	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
06/22/2011	EXAMINERS AMENDMENT MAILED	O - Outgoing Correspondence	CNEA - EXAMINERS AMENDMENT MAILED
06/22/2011	EXAMINER'S AMENDMENT ENTERED	I - Incoming Correspondence	XAEC - EXAMINER'S AMENDMENT ENTERED
06/22/2011	EXAMINERS AMENDMENT -WRITTEN	R - Renewal	CNEA - EXAMINERS AMENDMENT -WRITTEN
06/17/2011	PREVIOUS ALLOWANCE COUNT WITHDRAWN	Z - Deletion	ZZZX - PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/13/2011	WITHDRAWN FROM PUB - OG REVIEW QUERY	Z - Deletion	PBCR
06/02/2011	LAW OFFICE PUBLICATION REVIEW COMPLETED	O - Outgoing Correspondence	PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
05/16/2011	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
05/13/2011	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2011	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
05/12/2011	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/23/2010	PRIORITY ACTION MAILED	F - First Action	CPRA - PRIORITY ACTION MAILED
11/22/2010	PRIORITY ACTION WRITTEN	R - Renewal	CPRA - PRIORITY ACTION WRITTEN
11/18/2010	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
11/03/2010	NOTICE OF DESIGN SEARCH CODE MAILED	O - Outgoing Correspondence	MDSC
11/02/2010	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
11/01/2010	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Some parts © 2024 Advameg, Inc.